Insider Transactions in Q2 2024 at Kyverna Therapeutics, Inc. (KYTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Karen Marie Walker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,636
+50.0%
|
$38,544
$4.42 P/Share
|
|
May 28
2024
|
Ryan Alexander Jones Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,016
+18.39%
|
$0
$0.73 P/Share
|